Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
EG Chiorean, AL Coveler - Drug design, development and therapy, 2015 - Taylor & Francis
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
EG Chiorean, AL Coveler - Drug Design, Development and Therapy, 2015 - dovepress.com
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.
EG Chiorean, AL Coveler - Drug Design, Development and Therapy, 2015 - europepmc.org
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
[HTML][HTML] Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
EG Chiorean, AL Coveler - Drug Design, Development and …, 2015 - ncbi.nlm.nih.gov
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
[引用][C] Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
EG Chiorean, A Coveler - Drug Design, Development and Therapy, 2015 - cir.nii.ac.jp
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
EG Chiorean, AL Coveler - Drug Design, Development and Therapy, 2015 - go.gale.com
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
EG Chiorean, AL Coveler - Drug design, development …, 2015 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
EG Chiorean, AL Coveler - Drug Design, Development and Therapy, 2015 - hero.epa.gov
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.
EG Chiorean, AL Coveler - Drug Design, Development and Therapy, 2015 - europepmc.org
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …